C-Src/Cav1-dependent activation of the EGFR by Dsg2

Andrew M. Overmiller, Kathleen P. McGuinn, Brett J. Roberts, Felicia Cooper, Donna M. Brennan-Crispi, Takahiro Deguchi, Sirkku Peltonen, James K Wahl, My G. Mahoney

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The desmosomal cadherin, desmoglein 2 (Dsg2), is deregulated in a variety of human cancers including those of the skin. When ectopically expressed in the epidermis of transgenic mice, Dsg2 activates multiple mitogenic signaling pathways and increases susceptibility to tumorigenesis. However, the molecular mechanism responsible for Dsg2-mediated cellular signaling is poorly understood. Here we show overexpression as well as co-localization of Dsg2 and EGFR in cutaneous SCCs in vivo. Using HaCaT keratinocytes, knockdown of Dsg2 decreases EGFR expression and abrogates the activation of EGFR, c-Src and Stat3, but not Erk1/2 or Akt, in response to EGF ligand stimulation. To determine whether Dsg2 mediates signaling through lipid microdomains, sucrose density fractionation illustrated that Dsg2 is recruited to and displaces Cav1, EGFR and c-Src from light density lipid raft fractions. STED imaging confirmed that the presence of Dsg2 disperses Cav1 from the cellcell borders. Perturbation of lipid rafts with the cholesterol-chelating agent MβCD also shifts Cav1, c-Src and EGFR out of the rafts and activates signaling pathways. Functionally, overexpression of Dsg2 in human SCC A431 cells enhances EGFR activation and increases cell proliferation and migration through a c-Src and EGFR dependent manner. In summary, our data suggest that Dsg2 stimulates cell growth and migration by positively regulating EGFR level and signaling through a c-Src and Cav1-dependent mechanism using lipid rafts as signal modulatory platforms.

Original languageEnglish (US)
Pages (from-to)37536-37555
Number of pages20
JournalOncotarget
Volume7
Issue number25
DOIs
StatePublished - Jan 1 2016

Fingerprint

Desmoglein 2
Lipids
Cell Movement
Desmosomal Cadherins
Skin
Cadherins
Chelating Agents
Keratinocytes
Epidermal Growth Factor
Epidermis
Transgenic Mice
Sucrose

Keywords

  • C-Src
  • Caveolin-1
  • Desmoglein-2
  • EGFR
  • Stat3

ASJC Scopus subject areas

  • Oncology

Cite this

Overmiller, A. M., McGuinn, K. P., Roberts, B. J., Cooper, F., Brennan-Crispi, D. M., Deguchi, T., ... Mahoney, M. G. (2016). C-Src/Cav1-dependent activation of the EGFR by Dsg2. Oncotarget, 7(25), 37536-37555. https://doi.org/10.18632/oncotarget.7675

C-Src/Cav1-dependent activation of the EGFR by Dsg2. / Overmiller, Andrew M.; McGuinn, Kathleen P.; Roberts, Brett J.; Cooper, Felicia; Brennan-Crispi, Donna M.; Deguchi, Takahiro; Peltonen, Sirkku; Wahl, James K; Mahoney, My G.

In: Oncotarget, Vol. 7, No. 25, 01.01.2016, p. 37536-37555.

Research output: Contribution to journalArticle

Overmiller, AM, McGuinn, KP, Roberts, BJ, Cooper, F, Brennan-Crispi, DM, Deguchi, T, Peltonen, S, Wahl, JK & Mahoney, MG 2016, 'C-Src/Cav1-dependent activation of the EGFR by Dsg2', Oncotarget, vol. 7, no. 25, pp. 37536-37555. https://doi.org/10.18632/oncotarget.7675
Overmiller AM, McGuinn KP, Roberts BJ, Cooper F, Brennan-Crispi DM, Deguchi T et al. C-Src/Cav1-dependent activation of the EGFR by Dsg2. Oncotarget. 2016 Jan 1;7(25):37536-37555. https://doi.org/10.18632/oncotarget.7675
Overmiller, Andrew M. ; McGuinn, Kathleen P. ; Roberts, Brett J. ; Cooper, Felicia ; Brennan-Crispi, Donna M. ; Deguchi, Takahiro ; Peltonen, Sirkku ; Wahl, James K ; Mahoney, My G. / C-Src/Cav1-dependent activation of the EGFR by Dsg2. In: Oncotarget. 2016 ; Vol. 7, No. 25. pp. 37536-37555.
@article{3637e30e22d84eb68af41cf76bdca093,
title = "C-Src/Cav1-dependent activation of the EGFR by Dsg2",
abstract = "The desmosomal cadherin, desmoglein 2 (Dsg2), is deregulated in a variety of human cancers including those of the skin. When ectopically expressed in the epidermis of transgenic mice, Dsg2 activates multiple mitogenic signaling pathways and increases susceptibility to tumorigenesis. However, the molecular mechanism responsible for Dsg2-mediated cellular signaling is poorly understood. Here we show overexpression as well as co-localization of Dsg2 and EGFR in cutaneous SCCs in vivo. Using HaCaT keratinocytes, knockdown of Dsg2 decreases EGFR expression and abrogates the activation of EGFR, c-Src and Stat3, but not Erk1/2 or Akt, in response to EGF ligand stimulation. To determine whether Dsg2 mediates signaling through lipid microdomains, sucrose density fractionation illustrated that Dsg2 is recruited to and displaces Cav1, EGFR and c-Src from light density lipid raft fractions. STED imaging confirmed that the presence of Dsg2 disperses Cav1 from the cellcell borders. Perturbation of lipid rafts with the cholesterol-chelating agent MβCD also shifts Cav1, c-Src and EGFR out of the rafts and activates signaling pathways. Functionally, overexpression of Dsg2 in human SCC A431 cells enhances EGFR activation and increases cell proliferation and migration through a c-Src and EGFR dependent manner. In summary, our data suggest that Dsg2 stimulates cell growth and migration by positively regulating EGFR level and signaling through a c-Src and Cav1-dependent mechanism using lipid rafts as signal modulatory platforms.",
keywords = "C-Src, Caveolin-1, Desmoglein-2, EGFR, Stat3",
author = "Overmiller, {Andrew M.} and McGuinn, {Kathleen P.} and Roberts, {Brett J.} and Felicia Cooper and Brennan-Crispi, {Donna M.} and Takahiro Deguchi and Sirkku Peltonen and Wahl, {James K} and Mahoney, {My G.}",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.7675",
language = "English (US)",
volume = "7",
pages = "37536--37555",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "25",

}

TY - JOUR

T1 - C-Src/Cav1-dependent activation of the EGFR by Dsg2

AU - Overmiller, Andrew M.

AU - McGuinn, Kathleen P.

AU - Roberts, Brett J.

AU - Cooper, Felicia

AU - Brennan-Crispi, Donna M.

AU - Deguchi, Takahiro

AU - Peltonen, Sirkku

AU - Wahl, James K

AU - Mahoney, My G.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The desmosomal cadherin, desmoglein 2 (Dsg2), is deregulated in a variety of human cancers including those of the skin. When ectopically expressed in the epidermis of transgenic mice, Dsg2 activates multiple mitogenic signaling pathways and increases susceptibility to tumorigenesis. However, the molecular mechanism responsible for Dsg2-mediated cellular signaling is poorly understood. Here we show overexpression as well as co-localization of Dsg2 and EGFR in cutaneous SCCs in vivo. Using HaCaT keratinocytes, knockdown of Dsg2 decreases EGFR expression and abrogates the activation of EGFR, c-Src and Stat3, but not Erk1/2 or Akt, in response to EGF ligand stimulation. To determine whether Dsg2 mediates signaling through lipid microdomains, sucrose density fractionation illustrated that Dsg2 is recruited to and displaces Cav1, EGFR and c-Src from light density lipid raft fractions. STED imaging confirmed that the presence of Dsg2 disperses Cav1 from the cellcell borders. Perturbation of lipid rafts with the cholesterol-chelating agent MβCD also shifts Cav1, c-Src and EGFR out of the rafts and activates signaling pathways. Functionally, overexpression of Dsg2 in human SCC A431 cells enhances EGFR activation and increases cell proliferation and migration through a c-Src and EGFR dependent manner. In summary, our data suggest that Dsg2 stimulates cell growth and migration by positively regulating EGFR level and signaling through a c-Src and Cav1-dependent mechanism using lipid rafts as signal modulatory platforms.

AB - The desmosomal cadherin, desmoglein 2 (Dsg2), is deregulated in a variety of human cancers including those of the skin. When ectopically expressed in the epidermis of transgenic mice, Dsg2 activates multiple mitogenic signaling pathways and increases susceptibility to tumorigenesis. However, the molecular mechanism responsible for Dsg2-mediated cellular signaling is poorly understood. Here we show overexpression as well as co-localization of Dsg2 and EGFR in cutaneous SCCs in vivo. Using HaCaT keratinocytes, knockdown of Dsg2 decreases EGFR expression and abrogates the activation of EGFR, c-Src and Stat3, but not Erk1/2 or Akt, in response to EGF ligand stimulation. To determine whether Dsg2 mediates signaling through lipid microdomains, sucrose density fractionation illustrated that Dsg2 is recruited to and displaces Cav1, EGFR and c-Src from light density lipid raft fractions. STED imaging confirmed that the presence of Dsg2 disperses Cav1 from the cellcell borders. Perturbation of lipid rafts with the cholesterol-chelating agent MβCD also shifts Cav1, c-Src and EGFR out of the rafts and activates signaling pathways. Functionally, overexpression of Dsg2 in human SCC A431 cells enhances EGFR activation and increases cell proliferation and migration through a c-Src and EGFR dependent manner. In summary, our data suggest that Dsg2 stimulates cell growth and migration by positively regulating EGFR level and signaling through a c-Src and Cav1-dependent mechanism using lipid rafts as signal modulatory platforms.

KW - C-Src

KW - Caveolin-1

KW - Desmoglein-2

KW - EGFR

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=84978086444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978086444&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.7675

DO - 10.18632/oncotarget.7675

M3 - Article

C2 - 26918609

AN - SCOPUS:84978086444

VL - 7

SP - 37536

EP - 37555

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 25

ER -